Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
410 9 |
Ultima descărcare din IBN: 2023-12-12 14:31 |
Căutarea după subiecte similare conform CZU |
616.91:578.834:616.33/34-053.2 (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585) |
Virologie (442) |
SM ISO690:2012 CAZAN, Corina, DOBROTĂ, Luminiţa, REVENCO, Ninel, HADJIU, Svetlana, CÎRSTEA (BUGA), Olga. Infecția SARS-CoV-2 și boala inflamatorie intestinală pediatrică. In: Buletin de Perinatologie, 2021, nr. 2(91), pp. 94-97. ISSN 1810-5289. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletin de Perinatologie | ||||||
Numărul 2(91) / 2021 / ISSN 1810-5289 | ||||||
|
||||||
CZU: 616.91:578.834:616.33/34-053.2 | ||||||
Pag. 94-97 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Inflammatory Bowel Disease represented by Crohn’s disease and ulcerative colitis is a condition with immunological and inflammatory pathogenesis the consequence of the action of environmental factors on genetic susceptibility. The recent pandemic caused by the new coronavirus has led to an ongoing global health crisis. The current epidemiological context is related to major challenges for pediatric gastroenterologists. Understanding the pathophysiological mechanisms for COVID-19 provides answers to one of the key questions such as: whether patients with IBD have a particular susceptibility to SARS-CoV-2 infection due to gastrointestinal ACE2 receptor expression. A necessary answer is how to deal immunosuppressive and immunomodulatory therapy and the role of therapy with biological agents in the pediatric IBD patient. |
||||||
Cuvinte-cheie COVID-19, receptor ACE2, immunomodulation, COVID-19, receptor ACE2, imunomodulare |
||||||
|